61 related articles for article (PubMed ID: 25876631)
1. Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance.
van Duin D; Cober ED; Richter SS; Perez F; Cline M; Kaye KS; Kalayjian RC; Salata RA; Evans SR; Fowler VG; Bonomo RA
Clin Microbiol Infect; 2014 Dec; 20(12):O1117-20. PubMed ID: 24931918
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the synergistic effect of eravacycline and tigecycline against carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae.
Huang YS; Yang JL; Wang JT; Sheng WH; Yang CJ; Chuang YC; Chang SC
J Infect Public Health; 2024 May; 17(5):929-937. PubMed ID: 38599013
[TBL] [Abstract][Full Text] [Related]
3. Colistin Resistance in Carbapenem-Resistant Klebsiella pneumoniae: Laboratory Detection and Impact on Mortality.
Rojas LJ; Salim M; Cober E; Richter SS; Perez F; Salata RA; Kalayjian RC; Watkins RR; Marshall S; Rudin SD; Domitrovic TN; Hujer AM; Hujer KM; Doi Y; Kaye KS; Evans S; Fowler VG; Bonomo RA; van Duin D;
Clin Infect Dis; 2017 Mar; 64(6):711-718. PubMed ID: 27940944
[TBL] [Abstract][Full Text] [Related]
4. Complex prosthetic joint infections due to carbapenemase-producing Klebsiella pneumoniae: a unique challenge in the era of untreatable infections.
de Sanctis J; Teixeira L; van Duin D; Odio C; Hall G; Tomford JW; Perez F; Rudin SD; Bonomo RA; Barsoum WK; Joyce M; Krebs V; Schmitt S
Int J Infect Dis; 2014 Aug; 25():73-8. PubMed ID: 24813874
[TBL] [Abstract][Full Text] [Related]
5. sRNA expression profile of KPC-2-producing carbapenem-resistant Klebsiella pneumoniae: Functional role of sRNA51.
Bai Y; Xie C; Zhang Y; Zhang Z; Liu J; Cheng G; Li Y; Wang D; Cui B; Liu Y; Qin X
PLoS Pathog; 2024 May; 20(5):e1012187. PubMed ID: 38718038
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors for Carbapenem-Resistant Klebsiella pneumoniae Infection: A Meta-Analysis.
Liu P; Li X; Luo M; Xu X; Su K; Chen S; Qing Y; Li Y; Qiu J
Microb Drug Resist; 2018 Mar; 24(2):190-198. PubMed ID: 28749714
[TBL] [Abstract][Full Text] [Related]
7. Combating Aminoglycoside Resistance: From Structural and Functional Characterisation to Therapeutic Challenges with RKAAT.
Otun SO; Graca R; Achilonu I
Curr Protein Pept Sci; 2024; 25(6):454-468. PubMed ID: 38314602
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapies against antibiotics-resistant Klebsiella pneumoniae.
Xiao X; Wu H; Dall'Acqua WF
Hum Vaccin Immunother; 2016 Dec; 12(12):3097-3098. PubMed ID: 27431874
[No Abstract] [Full Text] [Related]
9. Structural basis for carbapenem-hydrolyzing mechanisms of carbapenemases conferring antibiotic resistance.
Jeon JH; Lee JH; Lee JJ; Park KS; Karim AM; Lee CR; Jeong BC; Lee SH
Int J Mol Sci; 2015 Apr; 16(5):9654-92. PubMed ID: 25938965
[TBL] [Abstract][Full Text] [Related]
10. The pros, cons, and unknowns of search and destroy for carbapenem-resistant enterobacteriaceae.
Moodley P; Whitelaw A
Curr Infect Dis Rep; 2015 Jun; 17(6):483. PubMed ID: 25916995
[TBL] [Abstract][Full Text] [Related]
11. Formation of a carbapenemase resistance detection algorithm for use in the routine laboratory.
Boran N; Vivian B; Logan C; Grogan J
Br J Biomed Sci; 2015; 72(1):12-22. PubMed ID: 25906486
[TBL] [Abstract][Full Text] [Related]
12. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study.
Tumbarello M; Trecarichi EM; De Rosa FG; Giannella M; Giacobbe DR; Bassetti M; Losito AR; Bartoletti M; Del Bono V; Corcione S; Maiuro G; Tedeschi S; Celani L; Cardellino CS; Spanu T; Marchese A; Ambretti S; Cauda R; Viscoli C; Viale P;
J Antimicrob Chemother; 2015 Jul; 70(7):2133-43. PubMed ID: 25900159
[TBL] [Abstract][Full Text] [Related]
13. Interplay between ESKAPE Pathogens and Immunity in Skin Infections: An Overview of the Major Determinants of Virulence and Antibiotic Resistance.
Vale de Macedo GHR; Costa GDE; Oliveira ER; Damasceno GV; Mendonça JSP; Silva LDS; Chagas VL; Bazán JMN; Aliança ASDS; Miranda RCM; Zagmignan A; Monteiro AS; Nascimento da Silva LC
Pathogens; 2021 Feb; 10(2):. PubMed ID: 33540588
[TBL] [Abstract][Full Text] [Related]
14. [Controlling infection and spread of carbapenems-resistant Klebsiella pneumoniae among burn patients].
Huan J
Zhonghua Shao Shang Za Zhi; 2015 Feb; 31(1):5-8. PubMed ID: 25876631
[TBL] [Abstract][Full Text] [Related]
15. [Further understanding of infection of carbapenems-resistant
Xiang J; Huan JN
Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):790-795. PubMed ID: 30481920
[TBL] [Abstract][Full Text] [Related]
16. [Preliminary study on resistance mechanism and virulence features in carbapenems-resistant
Chen Z; Xiang J
Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):796-801. PubMed ID: 30481921
[No Abstract] [Full Text] [Related]
17. [Epidemiology investigation of carbapenems-resistant
Gong YL; Liu CJ; Luo XQ; Liu MX; Zhang C; Shi YL; Peng YZ
Zhonghua Shao Shang Za Zhi; 2019 Nov; 35(11):798-803. PubMed ID: 31775468
[No Abstract] [Full Text] [Related]
18. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection.
Hirsch EB; Tam VH
J Antimicrob Chemother; 2010 Jun; 65(6):1119-25. PubMed ID: 20378670
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports.
Lee GC; Burgess DS
Ann Clin Microbiol Antimicrob; 2012 Dec; 11():32. PubMed ID: 23234297
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
